We are live on ! Find out more
M1FG

Mach-1 Financial Group Portfolio holdings

AUM $258M
1-Year Est. Return 22.48%
This Fund
S&P 500
This Quarter Est. Return
+11.38%
1 Year Est. Return
+22.48%
3 Year Est. Return
+83.38%
5 Year Est. Return
+108.68%
10 Year Est. Return
AUM
$264M
AUM Growth
+$22.5M
Cap. Flow
-$8.15M
Cap. Flow %
-3.09%
Top 10 Hldgs %
29.57%
Holding
289
New
92
Increased
44
Reduced
83
Closed
65

Sector Composition

Rank Sector Weight
1 Technology 16.92%
2 Financials 11.63%
3 Healthcare 9.01%
4 Consumer Staples 7.15%
5 Consumer Discretionary 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEAT icon
126
Vivid Seats
SEAT
$84.6M
$470K 0.18%
+3,722
New +$510K
CUBI icon
127
Customers Bancorp
CUBI
$2.66B
$470K 0.18%
8,154
-5,913
-42% -$257K
BECN
128
DELISTED
Beacon Roofing Supply, Inc.
BECN
$470K 0.18%
+5,397
New +$423K
CHCO icon
129
City Holding Co
CHCO
$2.05B
$470K 0.18%
+4,259
New +$417K
RXST icon
130
RxSight
RXST
$249M
$467K 0.18%
11,593
-6,868
-37% -$201K
WING icon
131
Wingstop
WING
$3.53B
$467K 0.18%
+1,821
New +$393K
SKWD icon
132
Skyward Specialty Insurance
SKWD
$2.43B
$465K 0.18%
+13,738
New +$422K
PEBO icon
133
Peoples Bancorp
PEBO
$1.5B
$465K 0.18%
+13,780
New +$401K
NTNX icon
134
Nutanix
NTNX
$16B
$465K 0.18%
9,741
-4,389
-31% -$178K
TRN icon
135
Trinity Industries
TRN
$2.49B
$464K 0.18%
+17,443
New +$419K
SPTS icon
136
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.1B
$463K 0.18%
15,950
-509
-3% -$14.7K
ACAD icon
137
Acadia Pharmaceuticals
ACAD
$4.43B
$461K 0.17%
+14,726
New +$352K
FIVE icon
138
Five Below
FIVE
$12B
$461K 0.17%
+2,163
New +$397K
CAMT icon
139
Camtek
CAMT
$6.18B
$454K 0.17%
6,548
-1,597
-20% -$97.2K
GTLB icon
140
GitLab
GTLB
$5.83B
$447K 0.17%
+7,106
New +$359K
AMBA icon
141
Ambarella
AMBA
$3.77B
$447K 0.17%
+7,297
New +$398K
TMDX icon
142
Transmedics
TMDX
$2.64B
$446K 0.17%
+5,652
New +$341K
YOU icon
143
Clear Secure
YOU
$5.57B
$443K 0.17%
21,430
-1,023
-5% -$19.9K
LEN icon
144
Lennar Class A
LEN
$19.8B
$441K 0.17%
3,060
-5,806
-65% -$699K
CRSP icon
145
CRISPR Therapeutics
CRSP
$4.73B
$441K 0.17%
+7,037
New +$389K
COHR icon
146
Coherent
COHR
$51.4B
$440K 0.17%
+10,110
New +$364K
GH icon
147
Guardant Health
GH
$21.7B
$437K 0.17%
16,160
-2,916
-15% -$76.5K
AMLP icon
148
Alerian MLP ETF
AMLP
$13B
$435K 0.17%
10,230
+2,047
+25% +$86.8K
PAYO icon
149
Payoneer
PAYO
$2.42B
$435K 0.17%
+83,478
New +$460K
HURN icon
150
Huron Consulting
HURN
$2.41B
$432K 0.16%
+4,200
New +$431K

Similar funds

Mach-1 Financial Group's Q4 2023 Portfolio in Review

As of Q4 2023, Mach-1 Financial Group held 289 positions worth $264M, up 9.3% from $241M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Mach-1 Financial Group withdrew a net $8.15M in Q4 2023, closing 65 positions and reducing 83 holdings. Its most notable exit was AdvisorShares Alpha DNA Equity Sentiment ETF, an estimated $7.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Mach-1 Financial Group opened a new position in FT Vest S&P 500 Dividend Aristocrats Target Income ETF worth $5.69M.

  • Mach-1 Financial Group's largest Q4 2023 buy was FT Vest S&P 500 Dividend Aristocrats Target Income ETF: 110,184 shares worth $5.69M.
  • Mach-1 Financial Group added most to First Trust Smith Opportunistic Fixed Income ETF in Q4 2023, an estimated $6.06M increase.
  • Mach-1 Financial Group's biggest Q4 2023 reduction was First Trust Smith Unconstrained Bond ETF, cutting an estimated $4.4M.
  • Mach-1 Financial Group fully exited AdvisorShares Alpha DNA Equity Sentiment ETF in Q4 2023, selling an estimated $7.74M.
  • Mach-1 Financial Group's ten largest holdings make up 30% of its $264M portfolio in Q4 2023.
  • Mach-1 Financial Group opened 92 new positions and closed 65 in Q4 2023.
  • Mach-1 Financial Group's portfolio value rose 9.3% quarter-over-quarter to $264M.

Based on Mach-1 Financial Group's 13F filing for Q4 2023, filed 5 Feb 2024.